Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,469 | 961 | 751 | 1,039 | 1,094 |
| Receivables | 1,600 | 968 | 595 | 669 | 1,390 |
| Other current assets | 0 | 0 | 0 | 0 | 499 |
| TOTAL | $3,108 | $2,017 | $1,637 | $2,208 | $3,578 |
| Non-Current Assets | |||||
| PPE Net | 62 | 16 | 8 | 10 | 10 |
| Other Non-Current Assets | 172 | 122 | 132 | 156 | 180 |
| TOTAL | $234 | $137 | $140 | $166 | $190 |
| Total Assets | $3,342 | $2,154 | $1,778 | $2,374 | $3,768 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 653 | 280 | 123 | 324 | 1,363 |
| Other current liabilities | 627 | 72 | 279 | 519 | 706 |
| TOTAL | $1,706 | $851 | $723 | $1,166 | $2,395 |
| Non-Current Liabilities | |||||
| Long Term Debt | 413 | 301 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 18 | 46 | 73 |
| TOTAL | $413 | $301 | $18 | $46 | $73 |
| Total Liabilities | $2,119 | $1,152 | $741 | $1,212 | $2,467 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 375 | 374 | 374 | 374 | 374 |
| Common Shares | 129 | 129 | 129 | 129 | 129 |
| Retained earnings | -12,665 | -12,880 | -12,845 | -12,719 | -12,580 |
| Other shareholders' equity | 70 | 70 | 70 | 70 | 70 |
| TOTAL | $1,223 | $1,002 | $1,037 | $1,162 | $1,300 |
| Total Liabilities And Equity | $3,342 | $2,154 | $1,778 | $2,374 | $3,768 |